{"id":"https://openalex.org/W2013714853","doi":"https://doi.org/10.1248/bpb.31.1159","title":"Tocilizumab, a Humanized Anti-interleukin-6 Receptor Antibody, Ameliorates Joint Swelling in Established Monkey Collagen-Induced Arthritis","display_name":"Tocilizumab, a Humanized Anti-interleukin-6 Receptor Antibody, Ameliorates Joint Swelling in Established Monkey Collagen-Induced Arthritis","alternate_titles":[],"publication_year":2008,"publication_date":"2008-06-01","ids":{"openalex":"https://openalex.org/W2013714853","doi":"https://doi.org/10.1248/bpb.31.1159","mag":"2013714853","pmid":"https://pubmed.ncbi.nlm.nih.gov/18520048"},"language":"en","primary_location":{"id":"doi:10.1248/bpb.31.1159","doi":"https://doi.org/10.1248/bpb.31.1159","is_oa":true,"landing_page_url":"https://doi.org/10.1248/bpb.31.1159","pdf_url":"https://www.jstage.jst.go.jp/article/bpb/31/6/31_6_1159/_pdf","source":{"id":"https://openalex.org/S165235614","display_name":"Biological and Pharmaceutical Bulletin","issn_l":"0918-6158","issn":["0918-6158","1347-5215"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","jufo-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310313382","host_organization_name":"Pharmaceutical Society of Japan","host_organization_lineage":["https://openalex.org/P4310313382"],"host_organization_lineage_names":["Pharmaceutical Society of Japan"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Biological and Pharmaceutical Bulletin","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2013714853"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://www.jstage.jst.go.jp/article/bpb/31/6/31_6_1159/_pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Yasushi Uchiyama","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405254473","display_name":"Chugai Pharmaceutical Co., Ltd. (Japan)","ror":"https://ror.org/01v743b94","country_code":"JP","type":"company","lineage":["https://openalex.org/I4405254473"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Yasushi Uchiyama","raw_affiliation_strings":["Product Research Department, Chugai Pharmaceutical Co., Ltd","Product Research Department, Chugai Pharmaceutical Co., Ltd., Gotemba, Shizuoka, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Product Research Department, Chugai Pharmaceutical Co., Ltd","institution_ids":["https://openalex.org/I4405254473"]},{"raw_affiliation_string":"Product Research Department, Chugai Pharmaceutical Co., Ltd., Gotemba, Shizuoka, Japan","institution_ids":["https://openalex.org/I4405254473"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003494866","display_name":"Keigo Yorozu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405254473","display_name":"Chugai Pharmaceutical Co., Ltd. (Japan)","ror":"https://ror.org/01v743b94","country_code":"JP","type":"company","lineage":["https://openalex.org/I4405254473"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Keigo Yorozu","raw_affiliation_strings":["Product Research Department, Chugai Pharmaceutical Co., Ltd"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Product Research Department, Chugai Pharmaceutical Co., Ltd","institution_ids":["https://openalex.org/I4405254473"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112132939","display_name":"Misato Hashizume","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405254473","display_name":"Chugai Pharmaceutical Co., Ltd. (Japan)","ror":"https://ror.org/01v743b94","country_code":"JP","type":"company","lineage":["https://openalex.org/I4405254473"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Misato Hashizume","raw_affiliation_strings":["Product Research Department, Chugai Pharmaceutical Co., Ltd"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Product Research Department, Chugai Pharmaceutical Co., Ltd","institution_ids":["https://openalex.org/I4405254473"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028092189","display_name":"Yoichiro Moriya","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405254473","display_name":"Chugai Pharmaceutical Co., Ltd. (Japan)","ror":"https://ror.org/01v743b94","country_code":"JP","type":"company","lineage":["https://openalex.org/I4405254473"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Yoichiro Moriya","raw_affiliation_strings":["Product Research Department, Chugai Pharmaceutical Co., Ltd"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Product Research Department, Chugai Pharmaceutical Co., Ltd","institution_ids":["https://openalex.org/I4405254473"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5066076081","display_name":"Masahiko Mihara","orcid":"https://orcid.org/0000-0002-0792-4009","observed_orcids":["https://orcid.org/0000-0002-0792-4009"]},"institutions":[{"id":"https://openalex.org/I4405254473","display_name":"Chugai Pharmaceutical Co., Ltd. (Japan)","ror":"https://ror.org/01v743b94","country_code":"JP","type":"company","lineage":["https://openalex.org/I4405254473"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Masahiko Mihara","raw_affiliation_strings":["Product Research Department, Chugai Pharmaceutical Co., Ltd"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Product Research Department, Chugai Pharmaceutical Co., Ltd","institution_ids":["https://openalex.org/I4405254473"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4405254473"],"apc_list":null,"apc_paid":null,"fwci":2.6436,"has_fulltext":true,"cited_by_count":55,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.8852671,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":98},"biblio":{"volume":"31","issue":"6","first_page":"1159","last_page":"1163"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10200","display_name":"Rheumatoid Arthritis Research and Therapies","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10200","display_name":"Rheumatoid Arthritis Research and Therapies","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13026","display_name":"Natural Compounds in Disease Treatment","score":0.00139999995008111,"subfield":{"id":"https://openalex.org/subfields/2707","display_name":"Complementary and alternative medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11616","display_name":"Autoimmune and Inflammatory Disorders Research","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/tocilizumab","display_name":"tocilizumab","score":1.0},{"id":"https://openalex.org/keywords/il-6-receptor","display_name":"IL-6 receptor","score":0.9229999780654907},{"id":"https://openalex.org/keywords/collagen-induced-arthritis","display_name":"collagen-induced arthritis","score":0.8209999799728394},{"id":"https://openalex.org/keywords/cynomolgus-monkey-model","display_name":"cynomolgus monkey model","score":0.8040000200271606},{"id":"https://openalex.org/keywords/joint-swelling","display_name":"joint swelling","score":0.9470000267028809},{"id":"https://openalex.org/keywords/anti-arthritic-activity","display_name":"anti-arthritic activity","score":0.6539999842643738},{"id":"https://openalex.org/keywords/neutrophil-infiltration","display_name":"neutrophil infiltration","score":0.8500000238418579},{"id":"https://openalex.org/keywords/soluble-il-6-receptor","display_name":"soluble IL-6 receptor","score":0.9300000071525574},{"id":"https://openalex.org/keywords/rheumatoid-arthritis","display_name":"rheumatoid arthritis","score":0.597000002861023}],"concepts":[{"id":"https://openalex.org/C2777178219","wikidata":"https://www.wikidata.org/wiki/Q425154","display_name":"Tocilizumab","level":3,"score":0.9717894792556763},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8249706029891968},{"id":"https://openalex.org/C2777077863","wikidata":"https://www.wikidata.org/wiki/Q170990","display_name":"Arthritis","level":2,"score":0.7194629311561584},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.5277693271636963},{"id":"https://openalex.org/C2777575956","wikidata":"https://www.wikidata.org/wiki/Q187255","display_name":"Rheumatoid arthritis","level":2,"score":0.4391290545463562},{"id":"https://openalex.org/C2777092746","wikidata":"https://www.wikidata.org/wiki/Q5939625","display_name":"Humanized antibody","level":4,"score":0.4323526620864868},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.39423057436943054},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.38480469584465027},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.18126773834228516}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000894","descriptor_name":"Anti-Inflammatory Agents, Non-Steroidal","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D000906","descriptor_name":"Antibodies","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D001169","descriptor_name":"Arthritis, Experimental","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D001169","descriptor_name":"Arthritis, Experimental","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D001169","descriptor_name":"Arthritis, Experimental","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D002097","descriptor_name":"C-Reactive Protein","qualifier_ui":"Q000096","qualifier_name":"biosynthesis","is_major_topic":false},{"descriptor_ui":"D004487","descriptor_name":"Edema","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D004487","descriptor_name":"Edema","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005528","descriptor_name":"Foot","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D006225","descriptor_name":"Hand","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D007596","descriptor_name":"Joints","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D008252","descriptor_name":"Macaca fascicularis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015415","descriptor_name":"Biomarkers","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015850","descriptor_name":"Interleukin-6","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D019947","descriptor_name":"Receptors, Interleukin-6","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D019947","descriptor_name":"Receptors, Interleukin-6","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D020556","descriptor_name":"Neutrophil Infiltration","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D024043","descriptor_name":"Collagen Type II","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1248/bpb.31.1159","doi":"https://doi.org/10.1248/bpb.31.1159","is_oa":true,"landing_page_url":"https://doi.org/10.1248/bpb.31.1159","pdf_url":"https://www.jstage.jst.go.jp/article/bpb/31/6/31_6_1159/_pdf","source":{"id":"https://openalex.org/S165235614","display_name":"Biological and Pharmaceutical Bulletin","issn_l":"0918-6158","issn":["0918-6158","1347-5215"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","jufo-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310313382","host_organization_name":"Pharmaceutical Society of Japan","host_organization_lineage":["https://openalex.org/P4310313382"],"host_organization_lineage_names":["Pharmaceutical Society of Japan"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Biological and Pharmaceutical Bulletin","raw_type":"journal-article"},{"id":"pmid:18520048","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/18520048","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Biological & pharmaceutical bulletin","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1248/bpb.31.1159","doi":"https://doi.org/10.1248/bpb.31.1159","is_oa":true,"landing_page_url":"https://doi.org/10.1248/bpb.31.1159","pdf_url":"https://www.jstage.jst.go.jp/article/bpb/31/6/31_6_1159/_pdf","source":{"id":"https://openalex.org/S165235614","display_name":"Biological and Pharmaceutical Bulletin","issn_l":"0918-6158","issn":["0918-6158","1347-5215"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","jufo-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310313382","host_organization_name":"Pharmaceutical Society of Japan","host_organization_lineage":["https://openalex.org/P4310313382"],"host_organization_lineage_names":["Pharmaceutical Society of Japan"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Biological and Pharmaceutical Bulletin","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9763000011444092,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2013714853.pdf","grobid_xml":"https://content.openalex.org/works/W2013714853.grobid-xml"},"referenced_works_count":16,"referenced_works":["https://openalex.org/W1987192197","https://openalex.org/W2006708761","https://openalex.org/W2022713850","https://openalex.org/W2025117799","https://openalex.org/W2055928479","https://openalex.org/W2064998333","https://openalex.org/W2081451656","https://openalex.org/W2118877038","https://openalex.org/W2120051788","https://openalex.org/W2123253747","https://openalex.org/W2125212735","https://openalex.org/W2134461080","https://openalex.org/W2139339400","https://openalex.org/W2156316990","https://openalex.org/W2164066860","https://openalex.org/W2168822788"],"related_works":["https://openalex.org/W1966811266","https://openalex.org/W2064998333","https://openalex.org/W7098169701","https://openalex.org/W4213345212","https://openalex.org/W2412218850","https://openalex.org/W4301226672","https://openalex.org/W2047163949","https://openalex.org/W1508108563","https://openalex.org/W2039975114","https://openalex.org/W2085684863"],"abstract_inverted_index":{"We":[0],"examined":[1],"if":[2],"tocilizumab,":[3],"humanized":[4],"anti-interleukin-6":[5],"receptor":[6],"(IL-6R)":[7],"antibody,":[8],"can":[9],"ameliorate":[10],"joint":[11,118],"swelling":[12,119],"after":[13,46,89],"the":[14,26,47,66,75,105,132,159],"onset":[15,48],"of":[16,28,49,52,58,71,78,107,111,134,161,164],"arthritis":[17,20,149],"in":[18,33,120,131,141,150],"collagen-induced":[19],"(CIA).":[21],"CIA":[22,154],"was":[23,40,62,81,84,113,139],"induced":[24],"by":[25,64],"immunization":[27],"bovine":[29],"type":[30],"II":[31],"collagen":[32],"female":[34],"cynomolgus":[35],"monkeys.":[36],"Tocilizumab":[37,115],"(30":[38],"mg/kg)":[39],"administered":[41],"weekly":[42],"for":[43,158],"4":[44],"weeks":[45],"arthritis.":[50],"Swelling":[51],"16":[53],"proximal":[54],"interphalangeal":[55],"(PIP)":[56],"joints":[57,73,112,138],"hands":[59],"and":[60,68,74,92,99,152],"feet":[61],"monitored":[63],"measuring":[65],"longitudinal":[67],"transverse":[69],"axes":[70],"PIP":[72,80],"oval":[76],"area":[77],"each":[79],"calculated.":[82],"Serum":[83],"collected":[85],"once":[86],"a":[87],"week":[88],"tocilizumab":[90,146],"injection":[91],"blood":[93],"chemistry,":[94],"IL-6,":[95],"soluble":[96],"IL-6R":[97],"(sIL-6R),":[98],"anti-tocilizumab":[100,124],"antibody":[101],"were":[102],"measured.":[103],"At":[104],"end":[106],"study,":[108],"histopathological":[109],"examination":[110],"performed.":[114],"clearly":[116],"reduced":[117],"all":[121],"animals":[122],"without":[123],"antibody.":[125],"Histopathological":[126],"study":[127],"showed":[128],"significant":[129],"decrease":[130],"infiltration":[133],"neutrophils":[135],"into":[136],"inflamed":[137],"observed":[140],"tocilizumab-treated":[142],"animals.":[143],"In":[144],"conclusion,":[145],"improved":[147],"established":[148],"monkey":[151,153],"model":[155],"is":[156],"useful":[157],"analysis":[160],"anti-arthritic":[162],"effect":[163],"tocilizumab.":[165]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2013714853","counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":4},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":4},{"year":2014,"cited_by_count":4},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":7}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
